Study on the effectiveness of the combination of cepharanthin and low-intensity pulsed ultrasound for Sjogren's syndrome patients

Study on the effectiveness of the combination of cepharanthin and low-intensity pulsed ultrasound for Sjogren's syndrome patients - Study on the effectiveness of the combination of cepharanthin and low-intensity pulsed ultrasound for Sjogren's syndrome patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020224

Enrollment

Registered

2015-12-16

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren&#39

Interventions

Cephalanthin, Low-intensity-pulsed ultrasound

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Primary Sjogren's syndrome

Exclusion criteria

Exclusion criteria: Secondary Sjogren's syndrome, Xerostomia due to aging

Design outcomes

Primary

Measure	Time frame
Improvement of infiltrateon of lymphocytes	—

Secondary

Measure	Time frame
Increase in salivary flow, Improvement of CRP level	—

Countries

Japan

Contacts

Public ContactNobuhiko Kawai

Tokushima University Graduate School of Oral Sciences Department of Orthodontics and Dentofacial Orthopedics

kamo@tokushima-u.ac.jp088-633-7357

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Study on the effectiveness of the combination of cepharanthin and low-intensity pulsed ultrasound for Sjogren&#39;s syndrome patients